About
Born October 23, 1958 · Male
Sunil Shah is based out of Newcastle, Newcastle upon Tyne and is the Chair of the Board of Atelerix and also CEO, Co-Founder of o2h group. Sunil previously worked at India-UK Cancer Research Initiative as an Advisory Panel Member. Sunil Shah attended the University of Cambridge.
Experience
Cambridge Angels group
View →Board Member · 2018 – present
76London, England, United KingdomAngel Investment · Financial Services
- Chair of the Board · Atelerix2025 – present
- Chairman · One Nucleus2024 – present
- Executive Chairman · Alevin Therapeutics2022 – present
- Board Member · Kuano2021 – present
- Associate · Cambridge Judge Business School2020 – present
- Board Member · BioIndustry Association2020 – present
- Board Observer · Metrion Biosciences2019 – present
- Board Member · Oxford Drug Design2017 – present
- Chairman Of The Board · Exonate2015 – present
- Chairman Of The Board · OPAL Therapeutics2013 – present
- Chairman Of The Board · Oppilotech2013 – present
- CEO and Co-Founder · o2h group2003 – present
- CEO & Co-Founder · O2h Ventures2003 – present
- Chairman of Board · Exonate
Education
- INSEAD · Executive Education - Strategy - AOP - Achieving Outstanding Performance2008 – 2008
- Cambridge Judge Business School · Master of Philosophy, Management Studies - Strategy1995 – 1996
- Cranfield University · M.Sc., Automating Genomic Sequencing - Sanger Centre1994 – 1995
- University of Nottingham · Bachelor's degree1991 – 1994
People at Cambridge Angels group
Data from: crunchbase
